Clinical trials recruiting for Idiopathic Inflammatory Myopathies(IIM)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CD19/CD22/BCMA CAR-T cells(BZE2204) | 1 |
| Cyclophosphamide | 1 |
| Fludarabine | 1 |
| LUCAR-G79D T cells | 1 |
| Universal CD19 CAR-γδT Cell Injection | 1 |
Self-screener
Recruiting trials
- A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)
- An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases
- Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Related conditions
Trials recruiting for Idiopathic Inflammatory Myopathies(IIM) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Idiopathic Inflammatory Myopathies(IIM) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.